Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07OSS
|
||||
| Former ID |
DIB006592
|
||||
| Drug Name |
9cUAB-30
|
||||
| Synonyms |
UAB-112; UAB-20; UAB-30; UAB-75; UAB-76; UAB-8; Retinoic acid analogs (cancer), University of Alabama; (9Z)-UAB-30
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 1 | [528795] | ||
| Company |
University of Alabama at Birmingham
|
||||
| Canonical SMILES |
C\1(=C\C(=C/C=C/C(=C/C(=O)O)/C)\C)/c2c(CCC1)cccc2
|
||||
| CAS Number |
CAS 205252-59-1
|
||||
| Target and Pathway | |||||
| Target(s) | Retinoic acid receptor RXR-gamma | Target Info | Modulator | [528795] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.